The final session of SABCS 2021 highlighted some of the most important breast cancer results from the meeting and put the findings into context for day-to-day clinical practice. Read more
A panel of experts discussed some of the latest advances in early and advanced breast cancer, basic science, and translational research during the special session Year in Review on Friday. Read more
In her plenary lecture on Friday, medical oncologist Lisa A. Carey, MD, ScM, discussed triple negative breast cancer, including advancements in treatment options and implications for population health. Read more
During the plenary lecture on Thursday, Mitchell Dowsett, PhD, FMedSci, looked at genetic profiling from early research to clinical utility and addressed clinically critical questions that have yet to be answered. Read more
Friday's General Session included two studies into race as a factor in the incidence, severity, and treatment outcomes of breast cancer. Read more
INDUSTRY NEWS
Time is running out to visit the SABCS 2021 exhibit hall and explore the latest industry advancements in breast cancer prevention and care. Read more
Industry exhibitors will showcase their latest breast cancer treatments, products, and technologies during five onsite presentations scheduled tomorrow. Read more
The hybrid nature of this year's SABCS would not have been possible without the generosity of numerous industry supporters. Read more